Ph.D., MPH, Vice President Commercial Markets, Tempus Inc.
In her current role, Suzanne focuses on commercial strategy and growth for Tempus developing and executing partnerships with organizations to improve healthcare value and outcomes by leveraging molecular and clinical data. Value creation for commercial payers, benefit managers and group purchasing organizations is where she focuses. Dr. Belinson is especially interested in applications of data to power solutions for the transition to and management of value based care. Prior to Tempus, Dr. Belinson served as Executive Director, Clinical Markets, at the Blue Cross Blue Shield Association where she led the sales and market development as well as day to day operations of Evidence Street. Dr. Belinson received her bachelor’s degree from Cleveland State University, a Masters in Public Health from the University of Pittsburgh, and a PhD in Epidemiology from the University of North Carolina at Chapel Hill.
AI and Data Sciences: Tempus Inc.
Tempus is a healthcare technology company with the goal for each patient to benefit from the treatment of others who came before.
Next Generation Managed Care
Tempus is revolutionizing cancer care with the largest connected clinical and genomic dataset aggregated from NCI-designated centers, Academic Medical Centers and community-based hospitals. Customized datasets can support commercial payers in monitoring and managing plan performance in real time.